• Info
  • Insider Ownership

Insider Trading & Ownership of ROCHE HOLDING LTD

Location
Basel
Summary
The estimated value of insider holdings of ROCHE HOLDING LTD is at least $47,939,139 dollars as of 07 Nov 2023. ROCHE HOLDING LTD is the 10%+ Owner of Entrada Therapeutics, Inc. and owns shares of Entrada Therapeutics, Inc. (TRDA) stock worth about $44.99M. ROCHE HOLDING LTD is the 10%+ Owner of Jasper Therapeutics, Inc. and owns shares of Jasper Therapeutics, Inc. (JSPR) stock worth about $2.95M.
Signature
ROCHE FINANCE LTD, By: /s/ Peter Trybus, Authorized Signatory
All Insider Reports
All Insider Reports

Notify me when ROCHE HOLDING LTD files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of ROCHE HOLDING LTD

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TRDA Entrada Therapeutics, Inc. 10%+ Owner $44,988,265 02 Nov 2021
JSPR, JSPRW Jasper Therapeutics, Inc. 10%+ Owner $2,950,874 25 Jan 2023
ALGS Aligos Therapeutics, Inc. 10%+ Owner 25 Oct 2023

Insider Transactions Reported by ROCHE HOLDING LTD:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.